Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells

Sulforaphane (SFN) is a natural micronutrient found in cruciferous vegetables that has been shown to possess antitumoral properties in carcinogen-treated rats. In vitro, SFN regulates phase II enzymes, cell cycle, and apoptosis. In the present study, we investigated the relationship between SFN induction of apoptosis and cell cycle arrest in HT29 human colon carcinoma cells. In previously published data, a significant increase in the G2/M phase of the cell cycle has been observed in SFN-treated cells that was associated with increased cyclin B1 protein levels. In the present study, our results show that SFN induced p21 expression. Moreover, preincubation of HT29 cells with roscovitine, a specific cdc2 kinase inhibitor, blocked the G2/M phase accumulation of HT29 cells treated with SFN and abolished its apoptotic effect (22.2 +/- 4 of floating cells in SFN-treated cells vs. 6.55 +/- 2 in cells treated with both SFN and roscovitine). These results suggest that the cdc2 kinase could be a key target for SFN in the regulation of G2/M block and apoptosis. Moreover, in SFN-treated cells the retinoblastoma tumor suppressor protein (Rb) is highly phosphorylated. Inhibition of the cdc2 kinase by roscovitine did not change the phosphorylation status of Rb in SFN-treated cells, suggesting that this cyclin-dependent kinase may not be involved. In our study, we did not observe any significant change in the proteasomal activity between control and SFN-treated cells. Moreover, inhibition of proteasomal activity through the use of MG132 diminished SFN-induced HT29 cell death, suggesting that the apoptotic effect of SFN requires a functional proteasome-dependent degradation system. In summary, we have elucidated part of the mechanism of action of SFN in the concomitant regulation of intestinal cell growth and death.     

Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells

Fisetin, a natural flavonol present in edible vegetables, fruits, and wine, was reported to exert anticarcinogenic effects. The objective of the current study was to examine the effect of fisetin on the cell cycle progression of the human colon cancer cell line HT-29. HT-29 cells were cultured in serum-free medium with 0, 20, 40, or 60 micromol/L fisetin. Fisetin dose dependently inhibited both cell growth and DNA synthesis (P < 0.05), with a 79 +/- 1% decrease in cell number observed 72 h after the addition of 60 micromol/L fisetin. Perturbed cell cycle progression from the G(1) to S phase was observed at 8 h with 60 micromol/L fisetin treatment, whereas a G(2)/M phase arrest was observed after 24 h (P < 0.05). The phosphorylation state of the retinoblastoma proteins shifted from hyperphosphorylated to hypophosphorylated in cells treated with 40 micromol/L fisetin. (P < 0.05). Fisetin decreased the activities of cyclin-dependent kinases (CDK)2 and CDK4; these effects were likely attributable to decreases in the levels of cyclin E and D1 and an increase in p21(CIP1/WAF1) levels (P < 0.05). However, fisetin also inhibited CDk4 activity in a cell-free system (P < 0.05), indicating that it may directly inhibit CDk4 activity. The protein levels of cell division cycles (CDC)2 and CDC25C and the activity of CDC2 were also decreased in fisetin-treated cells (P < 0.05). These results indicate that inhibition of cell cycle progression in HT-29 cells after treatment with fisetin can be explained, at least in part, by modification of CDK activities.     

Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells

The aim of present study was to investigate the effects of kaempferol on cellular proliferation and cell cycle arrest and explore the mechanism for these effects in human breast carcinoma MDA-MB-453 cells. Cells were treated with kaempferol at various concentrations (ranging from 1 to 200 µM) for 24 and 48 hrs. Kaempferol significantly inhibited cancer cell growth in cells exposed to 50 and 10 µM of kaempferol and incubated for 24 and 48 hrs, respectively. Exposure to kaempferol resulted in cell cycle arrest at the G2/M phase. Of the G2/M-phase related proteins, kaempferol down-regulated CDK1 and cyclin A and B in cells exposed to kaempferol. In addition, small DNA fragments at the sub-G0 phase were increased by up to 23.12 and 31.90% at 10 and 50 µM incubated for 24 and 48 hrs, respectively. The kaempferol-induced apoptosis was associated with the up-regulation of p53. In addition, the phosphorylation of p53 at the Ser-15 residue was observed with kaempferol. Kaempferol inhibits cell proliferation by disrupting the cell cycle, which is strongly associated with the induction of arrest at G2/M phase and may induce apoptosis via p53 phosphorylation in human breast carcinoma MDA-MB-453 cells.     

The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells

Summary. Background & aim: The resveratrol analogue piceatannol (3,5,3,4-tetrahydroxy-trans-stilbene; PICE) is a polyphenol present in grapes and wine. PICE is a protein kinase inhibitor that modifies multiple cellular targets exerting immunosuppressive, antileukemic and antitumorigenic activities in several cell lines and animal models. The present work aims to evaluate the antimelanoma effect of PICE on human melanoma cells for the first time. To this purpose, the pro-apoptotic capacity, uptake and metabolism of PICE as well as its effect on cell cycle and cyclins A, E and B1 expression will be studied. Methods: Human SK-Mel-28 melanoma cells were incubated with PICE (1–200 µM) for 72 hours. Cell cycle and viability were examined using flow cytometry analysis. Apoptosis was determined using the annexin V assay and also by fluorescence microscopy. Cyclins A, E and B1 were detected by Western blotting. Stability, cellular uptake and metabolism of PICE were evaluated using HPLC-DAD-MS-MS. Results: The lowest PICE concentration assayed (1 µM) increased about 6-fold over the control the apoptotic population of melanoma cells (10.2% at 8 hours which remained constant during 48 h). 100 µM PICE induced 13% apoptosis at 8 h increasing up to 41.5% at 48 h. The decrease in cell viability was highly correlated with the increase of apoptotic cells (R = 0.996; P < 0.0001) revealing that significant cytotoxic, unspecific effects did not occur in melanoma cells upon incubation with PICE. Cell cycle was arrested at G₂ phase which was supported by the down-regulation of cyclins A, E and B1. Two methyl-PICE derived metabolites, 3,5,4-trihydroxy-3-methoxy-trans-stilbene and 3,5,3-trihydroxy-4-methoxy-trans-stilbene (corresponding to 36% of the initially PICE added) were excreted by cells to the medium. The same methyl-PICE derivatives were also found inside the cells (0.01% of the initially PICE added; 0.0183 picograms/cell). Conclusion: The antimelanoma properties of dietary piceatannol cannot be ruled out taking into account its fast and potent pro-apoptotic capacity at low concentration (1 µM).     

视黄酸阻滞胎鼠腭间质细胞周期进程并诱导凋亡

目的探讨全反式视黄酸(atRA)对小鼠胚胎腭间质细胞(MEPM)细胞增殖和细胞周期的影响及其分子生物学作用机制。方法MEPM细胞取材于孕13d胎鼠腭组织。MTT比色法检测atRA对MEPM细胞增殖活力的影响;流式细胞术分析atRA对细胞周期分布的影响,并同时观察有无细胞凋亡现象发生;Western-blot检测atRA对细胞周期蛋白D和E表达的影响,并观察对视网膜母细胞瘤蛋白(Rb)磷酸化的影响。结果与溶剂对照组相比,在5~10μmol/L浓度范围内,atRA能够显著性抑制MEPM细胞增殖活力(P<0.05),并将细胞周期滞留在G0/G1期(P<0.05)。atRA对细胞周期蛋白D和E的表达及相应酶活性均表现为抑制效应。观察Rb的变化也显示,atRA降低Rb的磷酸化作用。结论atRA对腭器官发育敏感期腭间质细胞增殖活力及细胞周期的抑制作用可能是atRA诱导诱导唇腭裂的机制之一。     

共轭亚油酸对人乳腺癌细胞生长的抑制作用

目的 研究共轭亚油酸（c9,t11-CLA)对人乳腺癌细胞（MCF－7）生长的影响。方法 采用细胞核分裂指数、细胞生长曲线、细胞集落形成试验、^3H-TdR掺入试验和软琼脂培养方法,所设剂量（μmol/L）为25,50,100,200,以96％乙醇为溶剂对照。结果 在细胞核分裂指数、细胞生长曲线和细胞集落形成试验中,可见c9,t11-CLA对MCF－7细胞生长有明显的抑制作用,其作用于MCF－7细胞8d后的抑制率（％）分别为27．18、35．43、91．05和92．86;在^3H-TdR掺入试验中,可见随着c9,t11-CLA剂量的增加,^3H-TdR掺入到MCF－7细胞中明显的减少,与阴性对照组相比差异有显性;由软琼脂培养试验结果可见,随着c9,t11-CLA剂量的增加,MCF－7细胞的集落形成逐渐降低,除了25 μmol/L剂量组外与阴性对照组相比差异有显性。结论 c9,t11-CLA对MCF－7细胞的生长有明显的抑制作用。     

Deficiency in the 15 kDa selenoprotein inhibits human colon cancer cell growth

Selenium is an essential micronutrient for humans and animals, and is thought to provide protection against some forms of cancer. These protective effects appear to be mediated, at least in part, through selenium-containing proteins (selenoproteins). Recent studies in a mouse colon cancer cell line have shown that the 15 kDa selenoprotein (Sep15) may also play a role in promoting colon cancer. The current study investigated whether the effects of reversing the cancer phenotype observed when Sep15 was removed in mouse colon cancer cells, were recapitulated in HCT116 and HT29 human colorectal carcinoma cells. Targeted down-regulation of Sep15 using RNAi technology in these human colon cancer cell lines resulted in similarly decreased growth under anchorage-dependent and anchorage-independent conditions. However, the magnitude of reduction in cell growth was much less than in the mouse colon cancer cell line investigated previously. Furthermore, changes in cell cycle distribution were observed, indicating a delayed release of Sep15 deficient cells from the G(0)/G(1) phase after synchronization. The potential mechanism by which human colon cancer cells lacking Sep15 revert their cancer phenotype will need to be explored further.     

Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells

Lycopene is one of the major carotenoids and is found almost exclusively in tomatoes and tomato products. Since tomato consumption is associated with decreased risk of prostate cancer, characterizing the effects of lycopene on cell growth or survival, cell cycle progression, and apoptosis in LCNaP human prostate cancer cells might elucidate the mechanisms of actions of lycopene. To discover the possible anti-cancer mechanism of lycopene, water-soluble lycopene was used, and cell cycle arrest and apoptosis were measured. Placebo formulation at each lycopene dose at 0.1, 1, and 5 microM was used as a control. After 6, 24, and 48 hours of incubation, cells were harvested and measured for cell viability. Lycopene at 1 microM inhibited cell growth by 31%, compared with its placebo formulation after a 48-hour incubation. Lycopene at 5 microM increased the number of cells in the G(2)/M phase of the cell cycle from 13% to 28% and decreased S-phase cells from 45% to 29%, while no shifts in cell cycle were detected in placebo-treated groups. Apoptosis was observed at the 5 microM lycopene formulation at the late stages during the 24- and 48-hour treatments. Lycopene, therefore, deserves further study as a potential chemopreventive/chemotherapeutic agent.     

Benzyl isothiocyanate-induced DNA damage causes G2/M cell cycle arrest and apoptosis in human pancreatic cancer cells

Benzyl isothiocyanate (BITC) has been shown to inhibit chemically induced pancreatic cancer in experimental animals. However, the mechanism responsible for the anticancer effects of BITC is not clearly understood. In this study, we tested whether BITC treatment would affect the growth of Capan-2 human pancreatic cancer cells. BITC (10 micromol/L) treatment caused marked phosphorylation of H2A.x (2.6-fold) and permanent damage to Capan-2 cells. BITC-mediated G2/M arrest was associated with up-regulation of cyclin dependent kinase inhibitor p21(Waf1/Cip1) and the activation of checkpoint kinase 2, whereas the expressions of other G2/M regulatory proteins, including CyclinB1, Cdc2, and cell division cycle 25C (Cdc25C), were down-regulated by 19, 51, and 70%, respectively, compared with control. These changes resulted in a 55% inhibition of Cdc2 kinase activity. In addition, the decline in the expression of Cdc25C was completely blocked when the cells were treated with lactacystin (proteasome inhibitor) prior to BITC treatment. However, G2/M arrest and apoptosis induced by BITC were partially blocked by pretreatment of cells with lactacystin. Taken together, the results of this study suggest the involvement of multiple signaling pathways targeted by BITC in mediating G2/M cell cycle arrest and apoptosis in Capan-2 cells and warrant further investigation.     

Induction of apoptosis and cell cycle arrest in cancer cells by in vivo metabolites of teas

The present study was conducted to determine in vivo possibilities of inducing apoptosis and cell cycle arrest in rat cancer cells by green, oolong, and black teas and also to further identify the mechanisms inhibiting cancer cell proliferation by the sera from tea-treated rats. The tea extracts from these three kinds of tea, the rat sera obtained after oral intubation of the tea extracts, and the tea polyphenolic compounds, (-)-epigallocatechin-3-gallate, (-)-epigallocatechin, (-)-epicatechin-3-gallate, and the aflavins, were used in the related tests. The extracts, the sera from the treated rats, and the polyphenolic compounds significantly inhibited the proliferation of a rat hepatoma cell line (AH109A) and murine B16 melanoma cells but not normal rat mesothelial (M) cells. (-)-Epicatechin exhibited synergistic effects with (-)-epigallocatechin-3-gallate, (-)-epicatechin-3-gallate, and theaflavins against AH109A cell proliferation. The fluorescence staining of the nuclei, electrophoresis detection of DNA fragmentation, and analysis of cell cycle indicated that the sera from the tea-treated rats, the tea extracts, and the related tea components resulted in loss of viability, apoptosis, and cell cycle arrest at the G1 phase in AH109A and/or B16 cells, but not in normal M cells. Our results suggest that induction of apoptosis and cell cycle arrest may be important mechanisms of in vivo proliferation inhibition of AH109A and other cancer cells by these teas.     

科罗索酸对人结肠癌LoVo细胞裸鼠移植瘤的 抑制作用研究

摘要:目的　探讨科罗索酸对人结肠癌LoVo细胞株裸鼠移植瘤生长的影响极其作用机制。方法　LoVo细胞接种于裸鼠皮下制备裸鼠移植瘤模型。将造模成功的小鼠随机分成4组,分别灌胃给予0 mg/kg、5 mg/kg、10 mg/kg、20 mg/kg科罗索酸。每3 d测量肿瘤体积,连续给药24 d后剥离瘤块称重,计算抑瘤率;TUNEL技术检测细胞凋亡情况,Western blot检测细胞总STAT3及p-STAT3的表达。结果　科罗索酸低、中、高剂量组的抑瘤率分别是18.1%,45.7%（P＜0.05）和63.6%（P＜0.01）,肿瘤细胞的凋亡比率分别是（7.7±2.8）%,（13.3±4.3）%（P＜0.05）,（18.9±5.1）%（P＜0.01）,并呈剂量依赖性的抑制STAT3活化。结论　科罗索酸可抑制LoVo裸鼠移植瘤的生长,促进细胞凋亡,其机制可能与抑制STAT3的活化有关。     

Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention

Intake of dietary fiber may protect against colon cancer. The anticancer property is associated with an increased production of short chain fatty acids (SCFAs), including acetate, propionate and butyrate, during dietary fiber fermentation in the colon. However, the mechanisms remain to be determined. We hypothesized that butyrate exhibits a stronger inhibitory potential against colon cancer cell proliferation compared with acetate and propionate. We determined the half maximal inhibitory concentrations (IC₅₀) of SCFAs in HCT116 human colon cancer cell proliferation by examining cell growth curves. At 24- and 48-hour time points, IC₅₀ (mmol/L) concentrations of acetate, propionate, and butyrate were [66.0 and 29.0], [9.2 and 3.6], and [2.5 and 1.3], respectively. Consistent with the greater anti-proliferative effect, butyrate exhibits >3-fold stronger potential for inducing cell cycle arrest at the G2 phase with a drop in S-phase fraction (including c-Myc/p21 signaling) and apoptosis when compared with acetate and propionate. Subsequently, we focused on the effect of butyrate on apoptotic gene expression. Using a PCR array analysis, we identified 17 pro-apoptotic genes, 6 anti-apoptotic genes, and 4 cellular mediator genes with >1-fold increase or decrease in mRNA levels out of 93 apoptosis related genes in butyrate-treated HCT116 cells when compared with untreated HCT116 cells. These genes were mainly involved in the TNF, NFκB, CARD, and BCL-2 regulated pathways. Taken together, our data indicate a greater inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis.     

Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells

Prostate cancer is the second most common cancer in men. The disease etiology is poorly understood, but diet and lifestyle are contributory factors. Conjugated linoleic acids (CLAs), naturally occurring fatty acids in ruminant food products, have antitumor properties in animal models of cancer and antiproliferative effects on cancer cells in vitro. The cellular mechanisms by which CLAs elicit these effects are unclear, particularly for prostate cancer cells. We have previously identified protein kinase C (PKC) isoforms, alpha, delta, iota, mu, and zeta in LNCaP prostate cancer cells. The objective of this study was to determine the effects of CLAs (individual cis-9, trans-11 and trans-10, cis-12 isoforms and a 50:50 mixture) on PKC isoform abundance in LNCaP cells. Confluent cells were treated with 6, 25, and 50 microM CLA for 0.5, 6, and 24 h. Cytosol and membrane protein fractions were assayed for PKC isoforms (mainly alpha and delta but also iota, mu, and zeta) by Western blot analysis using specific antibodies. CLAs clearly modulated the abundance of these PKC isoforms, both positively and negatively, depending on the isoform, concentration of CLAs, and period of treatment. Increased PKC-delta and decreased PKC-iota membrane abundance was consistent with CLAs eliciting increased apoptosis and, in part, with their antitumor effects.     

二十二碳六烯酸对人胰腺癌细胞增殖的抑制

目的探讨二十二碳六烯酸（DHA）对人胰腺癌细胞株Patu8988和SW1990生长的作用。方法采用MTT法检测DHA作用后Patu8988和SW1990细胞的增殖,流式细胞术检测DHA作用后Patu8988和SWl990细胞的凋亡、细胞周期和肿瘤相关蛋白环氧合酶2（COX-2）的表达量。结果DHA作用人胰腺癌细胞株24、48、72h后,细胞的增殖受到明显抑制（P〈0．01）,同时DHA能诱导细胞凋亡,随着作用时间延长和作用剂量增加,效果越明显。50μg／ml DHA作用24h后,胰腺癌细胞的COX-2表达量下降（P〈0．05）。结论DHA能有效地抑制胰腺癌细胞增殖,同时诱导细胞凋亡,可能与COX-2在胰腺癌细胞中的表达下调有关。     

Increased carnitine-dependent fatty acid uptake into mitochondria of human colon cancer cells induces apoptosis

Carnitine-dependent fatty acid import into mitochondria and beta-oxidation seem to be impaired in tumor cells. In the present study we show that a supply of palmitoylcarnitine together with L-carnitine potently induces apoptosis in HT-29 human colon cancer cells as a consequence of accelerated fatty acid oxidation. Caspase-3-like activities, measured by the cleavage rate of a fluorogenic tetrapeptide substrate and nuclear fragmentation determined after DNA labeling in fixed cells by fluorescence microscopy, served as indicators of apoptosis. Neither L-carnitine nor palmitoylcarnitine alone were able to increase caspase-3-like activities and DNA fragmentation, but when provided together, apoptosis occurred. That exogenous carnitine was indeed able to enhance fatty acid uptake into mitochondria was demonstrated by an increased influx of a fluorescent palmitic acid analog. Enhanced fatty acid availability in mitochondria led to an increased generation of O*2-, as detected by a O*2- -sensitive fluorogenic dye, indicating oxidation of delivered substrates. Benzoquinone, an O*2- scavenger, blocked O*2- generation and prevented apoptosis as initiated by the combination of palmitoylcarnitine and carnitine. The lack of effect of the ceramide synthesis inhibitor fumonisin on palmitoylcarnitine/carnitine-induced apoptosis further supports the notion that apoptotic cell death is specifically due to fatty acid oxidation. In contrast to HT-29 cells, nontransformed human colonocytes did not respond to exogenous palmitoylcarnitine/carnitine and no apoptosis was observed. In conclusion, our studies provide evidence that a limited mitochondrial fatty acid import in human colon cancer cells prevents high rates of mitochondrial O*2- production and protects colon cancer cells from apoptosis that can be overcome by an exogenous carnitine supply.     

Ethanol extract of Innotus obliquus (Chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells

BACKGROUND/OBJECTIVES

Inonotus obliquus (I. obliquus, Chaga mushroom) has long been used as a folk medicine to treat cancer. In the present study, we examined whether or not ethanol extract of I. obliquus (EEIO) inhibits cell cycle progression in HT-29 human colon cancer cells, in addition to its mechanism of action.

MATERIALS/METHODS

To examine the effects of Inonotus obliquus on the cell cycle progression and the molecular mechanism in colon cancer cells, HT-29 human colon cancer cells were cultured in the presence of 2.5 - 10 µg/mL of EEIO, and analyzed the cell cycle arrest by flow cytometry and the cell cycle controlling protein expression by Western blotting.

RESULTS

Treatment cells with 2.5 - 10 µg/mL of EEIO reduced viable HT-29 cell numbers and DNA synthesis, increased the percentage of cells in G₁ phase, decreased protein expression of CDK2, CDK4, and cyclin D1, increased expression of p21, p27, and p53, and inhibited phosphorylation of Rb and E2F1 expression. Among I. obliquus fractions, fraction 2 (fractionated by dichloromethane from EEIO) showed the same effect as EEIO treatment on cell proliferation and cell cycle-related protein levels.

CONCLUSIONS

These results demonstrate that fraction 2 is the major fraction that induces G₁ arrest and inhibits cell proliferation, suggesting I. obliquus could be used as a natural anti-cancer ingredient in the food and/or pharmaceutical industry.     

Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells

Previous reports have documented the antiproliferative properties of a mixture of conjugated isomers (CLA) of linoleic acid [LA (18:2)]. In this study, we investigated the mechanisms of CLA action on cell cycle progression in breast and colon cancer cells. Treatment with CLA inhibited cell proliferation in breast cancer MCF-7 cells containing wild-type p53 (p53(+/+)). At cytostatic concentrations, CLA elicited cell cycle arrest in G1 and induced the accumulation of the tumor suppressors p53, p27 and p21 protein. Conversely, CLA reduced the expression of factors required for G1 to S-phase transition including cyclins D1 and E, and hyperphoshorylated retinoblastoma Rb protein. In contrast, the overexpression of mutant p53 (175Arg to His) in MFC-7 cells prevented the CLA-dependent accumulation of p21 and the reduction of cyclin E levels suggesting that the expression of wild-type p53 is required for CLA-mediated activation of the G1 restriction point. To further elucidate the role of p53, the effects of CLA in colon cancer HCT116 cells (p53(+/+)) and p53-deficient (p53(-/-)) HCT116 cells (HCTKO) were examined. The treatment of HCT116 cells with CLA increased the levels of p53, p21, p27 and hypophosphorylated (pRb) protein and reduced the expression of cyclin E, whereas these effects were not seen in p53-deficient HCTKO cells. The t10,c12-CLA isomer was more effective than c9,t11-CLA in inhibiting cell proliferation of MCF-7 breast cancer cells and enhancing the accumulation of p53 and pRb. We conclude that the antiproliferative properties of CLA appear to be a function, at least in part, of the relative content of specific isomers and their ability to elicit a p53 response that leads to the accumulation of pRb and cell growth arrest.     

人生长激素对人结肠癌细胞LS-174-T增殖周期的影响

目的：研究人生长激素（hGH)对体外培养的结肠癌细胞株增殖周期和DNA倍体的影响和意义。方法：取指数生长期的结肠癌细胞株LS-174-T（简称174）,以顺铂和（或）不同浓度的hGH体外培养,24h后以流式细胞仪测定细胞增殖周期等指标。结果：hGH能诱导174细胞S期数率显著上升（P＜0.01),G2/M期参数下调（P＜0.01),DNA指数未见增高。加用顺铂后细胞大量凋亡,细胞存活率显著下降（P＜0.01),各组S期百分数或显著下降,或与对照组无差异。结论：hGH体外作用于174细胞,能促使细胞进入对化疗药敏感的DNA合成期,没有上调DNA倍体数;顺铂能诱导大量凋亡,并且抑制hGH促进细胞增殖的作用。